CD44 and COVID-19: Others have reported that the lymphopenia associated with COVID-19 could be a consequence of pulmonary recruitment and entrapment of lymphocytes, due to modification of adhesion molecules (CD44, LFA-1 and ICAM-1) (Morris, 1998; Bohn et al., 2020).